These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6361053)

  • 1. Fluorescent-antibody reagents for the identification of Clostridium botulinum.
    Glasby C; Hatheway CL
    J Clin Microbiol; 1983 Dec; 18(6):1378-83. PubMed ID: 6361053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological studies of Clostridium botulinum type E and related organisms. II. Serology of spores.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    J Bacteriol; 1969 May; 98(2):407-14. PubMed ID: 4891254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous antibody production to botulinum toxin in an adult with intestinal colonization botulism and underlying Crohn's disease.
    Griffin PM; Hatheway CL; Rosenbaum RB; Sokolow R
    J Infect Dis; 1997 Mar; 175(3):633-7. PubMed ID: 9041335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescent study of the spore antigens of proteolytic strains of Clostridium botulinum.
    Princewill TJ
    J Hyg (Lond); 1979 Aug; 83(1):1-9. PubMed ID: 379206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfer of neurotoxigenicity from Clostridium butyricum to a nontoxigenic Clostridium botulinum type E-like strain.
    Zhou Y; Sugiyama H; Johnson EA
    Appl Environ Microbiol; 1993 Nov; 59(11):3825-31. PubMed ID: 8285687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a monoclonal antibody recognizing an antigenic site common to Clostridium botulinum type B, C1, D, and E toxins and tetanus toxin.
    Tsuzuki K; Yokosawa N; Syuto B; Ohishi I; Fujii N; Kimura K; Oguma K
    Infect Immun; 1988 Apr; 56(4):898-902. PubMed ID: 2450068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic similarity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Iida H; Kubo S
    Infect Immun; 1980 Dec; 30(3):656-60. PubMed ID: 6785231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
    Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
    Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning of a DNA sequence unique to Clostridium botulinum group I by selective hybridization.
    McKinney MW; Levett PN; Haylock RW
    J Clin Microbiol; 1993 Jul; 31(7):1845-9. PubMed ID: 8349762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
    Foynes S; Holley JL; Garmory HS; Titball RW; Fairweather NF
    Vaccine; 2003 Mar; 21(11-12):1052-9. PubMed ID: 12559779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interconversion of type C and D strains of Clostridium botulinum by specific bacteriophages.
    Eklund MW; Poysky FT
    Appl Microbiol; 1974 Jan; 27(1):251-8. PubMed ID: 4589131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual toxin-producing strain of Clostridium botulinum type Bf isolated from a California patient with infant botulism.
    Barash JR; Arnon SS
    J Clin Microbiol; 2004 Apr; 42(4):1713-5. PubMed ID: 15071029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of proteins, insoluble at low temperature, produced by Clostridium botulinum type C and C. subterminale. Their antigenic relationship with a similar protein synthesized by C. botulinum type G.
    Giménez JA; Vita N; Giménez DF; Paladini AC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):45-56. PubMed ID: 3314259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological studies of Clostridium botulinum type E and related organisms.
    Lynt RK; Solomon HM; Kautter DA; Lilly T
    J Bacteriol; 1967 Jan; 93(1):27-35. PubMed ID: 5335894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.